AIDS Education and Training Center National Clinician Consultation Center | HRSA 25 061

Frequently Asked Questions (FAQs) - HRSA-25-061 (AETC NCCC)

1) What is the HRSA-25-061 funding opportunity?

HRSA-25-061 is a Health Resources and Services Administration (HRSA) discretionary cooperative agreement to support the AIDS Education and Training Center (AETC) National Clinician Consultation Center (NCCC). The focus is strengthening the clinical workforce that delivers HIV prevention and care by providing rapid, expert clinical consultation and educational support to health care team members.

2) What is the core purpose of the National Clinician Consultation Center (NCCC)?

The NCCC exists to provide rapid, expert, and culturally competent clinical consultation so clinicians and other providers can make timely, evidence-informed decisions when caring for people with or at risk for HIV, including real-world cases, emerging issues, and complex co-morbidities that affect HIV outcomes.

3) What type of funding mechanism is used for this opportunity?

This opportunity uses a cooperative agreement mechanism. This generally means substantial federal involvement, with ongoing coordination and collaboration with HRSA during program implementation for the national consultation and training-support functions.

4) Who is the sponsoring agency?

The sponsoring agency is the Health Resources and Services Administration (HRSA).

5) How many awards does HRSA expect to make?

The notice indicates an expected single award (ExpectedAwards: 1).

6) What is the program designed to help clinicians do?

The program is designed to help health care team members make timely, evidence-informed clinical decisions by providing quick, practical guidance on HIV prevention and care, including complex clinical scenarios and co-morbidities that can impact outcomes.

7) What kinds of services does the NCCC provide?

The NCCC provides consultation and educational services delivered through multiple access points, including telephone-based warmlines, a hotline, and internet-based educational consultation.

8) What access channels are specifically mentioned in the opportunity description?

The opportunity description specifically mentions telephone-based warmlines, a hotline, and internet-based educational consultation as ways providers can access consultation and educational support.

9) What clinical topics are covered under the NCCC scope?

The clinical scope is broad and spans HIV prevention and treatment. It includes general HIV prevention, care, and treatment (diagnosis, testing strategies, and antiretroviral therapy decision-making), dedicated support for PrEP and PEP, management of hepatitis B and hepatitis C (especially with HIV coinfection), substance use disorders (including opioid use disorder and related co-morbidities), and perinatal HIV care to prevent perinatal transmission and support treatment during pregnancy and postpartum care.

10) Does the NCCC address both HIV prevention and HIV treatment?

Yes. The scope includes both prevention and treatment, with coverage of prevention strategies (including PrEP and PEP) and care/treatment topics such as diagnosis, testing strategies, and antiretroviral therapy decision-making.

11) Does the opportunity include support for PrEP and PEP consultations?

Yes. The NCCC includes dedicated support for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).

12) Are hepatitis B and hepatitis C included in the consultation scope?

Yes. The NCCC addresses treatment and management of hepatitis B and hepatitis C, particularly in the context of HIV coinfection.

13) Does the NCCC address substance use disorders in relation to HIV?

Yes. The opportunity includes care strategies for substance use disorders among people with or at risk for HIV, including opioid use disorder and related co-morbidities.

14) Is perinatal HIV care included in the program scope?

Yes. The NCCC includes perinatal HIV care and management to support prevention of perinatal transmission and appropriate treatment during pregnancy and postpartum care.

15) What does the opportunity mean by "rapid" clinical consultation?

Based on the description, "rapid" refers to clinicians being able to turn to the NCCC for quick, practical guidance to support timely decision-making on real-world cases and emerging issues. The specific response time standards are not provided in the information shared.

16) Who are the intended users of NCCC consultation services?

The intended users are health care team members, including clinicians and other providers, who care for people with or at risk for HIV and need expert guidance for clinical decision-making.

17) How is cultural competence and equity emphasized in this opportunity?

The NCCC is expected to provide culturally competent consultation and to be equity-oriented rather than one-size-fits-all. The opportunity highlights the need to effectively serve communities disproportionately affected by HIV, including communities where many people with HIV identify as members of non-white racial or ethnic groups.

18) What communities and settings are specifically highlighted as priorities?

The opportunity emphasizes relevance across Ending the HIV Epidemic (EHE) jurisdictions, rural communities, and areas experiencing disproportionate impacts from substance use disorders and other co-occurring health challenges.

19) How does the NCCC align with the Ryan White HIV/AIDS Program (RWHAP) Part F AETC Program?

The NCCC goals are aligned with the broader RWHAP Part F AETC Program goals, including expanding and diversifying the HIV workforce, improving health care team ability to deliver effective HIV prevention and care through skill-building and decision support, advancing health equity by integrating HIV services into primary care and other underserved settings, and strengthening overall AETC capacity to train health care team members serving people with or at risk for HIV.

20) What are the stated goals shared with the broader AETC Program?

The shared goals described are: (1) expand the number of health care team members who provide HIV care and prevention services (including growing and diversifying the provider pipeline); (2) improve health care team capability to deliver effective HIV care and prevention through skill-building and decision support; (3) advance health equity by integrating HIV services into primary care and other settings serving underserved populations; and (4) strengthen the overall AETC Program capacity to train health care team members to serve people with or at risk for HIV.

21) Who is eligible to apply for HRSA-25-061?

Eligibility is broad and includes state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; nonprofits with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); and other entities.

22) Are institutions of higher education eligible?

Yes. Both public/state-controlled institutions of higher education and private institutions of higher education are listed as eligible applicants.

23) Are nonprofit organizations eligible even if they do not have 501(c)(3) status?

Yes. The eligibility list includes nonprofits with or without 501(c)(3) status, with an exclusion noted for institutions of higher education within those nonprofit categories.

24) Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments and other tribal organizations are included in the eligibility list.

25) Where must applicants be located or operate?

Applicants must be based in, or operate within, the United States or specified U.S.-affiliated jurisdictions: the Commonwealth of Puerto Rico, Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.

26) What is the original closing date listed for this opportunity?

The notice lists an original closing date of February 10, 2025.

27) What is the CFDA number for this opportunity?

The opportunity is cataloged under CFDA 93.145.

28) What is the award ceiling for HRSA-25-061?

The award ceiling is listed as 0 in the provided source data. In this context, that typically means the ceiling is not specified in that field or may be defined elsewhere in the full announcement materials, rather than indicating there is no funding.

29) Does the information provided specify an award floor or a specific dollar amount?

No specific award floor or dollar amount is provided in the information shared here. The only related detail provided is that the award ceiling is listed as 0 in the source data field, which typically indicates "not specified" in that field.

30) What is the practical role of the NCCC in the national HIV workforce ecosystem?

Based on the description, the NCCC functions as a national resource that clinicians can use for quick, practical guidance to support higher-quality and more equitable HIV prevention and treatment, especially in settings with limited specialty access.